Pseudotumor Cerebri, also known as idiopathic intracranial hypertension (IIH) is a syndrome of elevated intracranial pressure (ICP) that occurs predominantly in obese women of childbearing age. Headaches and vision impairment are most commonly found in patients with Pseudotumor Cerebri. The visual symptoms may arise due to papilledema. Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. Market Analysis and Insights: Global Pseudotumor Cerebri Market The global Pseudotumor Cerebri market size is projected to reach US$ 12500 million by 2027, from US$ 8872 million in 2020, at a CAGR of 5.0% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pseudotumor Cerebri market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pseudotumor Cerebri market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pseudotumor Cerebri market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pseudotumor Cerebri market. Global Pseudotumor Cerebri Scope and Market Size Pseudotumor Cerebri market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pseudotumor Cerebri market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Fundoscopy Neuroimaging Lumbar Puncture Segment by Application Spinal Fluid Shunt Optic Nerve Sheath Fenestration Venous Sinus Stenting Medication By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Avkare, Inc. B. Braun Melsungen AG Beckersmith Medical, Inc. Elekta AB Heritage Pharmaceuticals Inc. Ingenus Pharmaceuticals Integra LifeSciences Corporation Johnson & Johnson Services, Inc. Lannett Company, Inc. Magstim Medtronic MercuryPharma Nostrum Laboratories Inc. Novast Holdings Ltd. Phoenix Biomedical Corp. Sanofi, SGPharma Pvt. Ltd. Sophysa Taro Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. West-Ward Pharmaceutical Zydus Pharmaceuticals, Inc.
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pseudotumor Cerebri Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Fundoscopy 1.2.3 Neuroimaging 1.2.4 Lumbar Puncture 1.3 Market by Application 1.3.1 Global Pseudotumor Cerebri Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Spinal Fluid Shunt
